Rapid increase in intravenous iron therapy for women of reproductive age in Australia

Pradeep Jayasuriya, Toby Richards and Bernd Froessler
Med J Aust 2021; 214 (6): . || doi: 10.5694/mja2.50980
Published online: 5 April 2021

To the Editor: We read with interest the analysis and comments by Shand and colleagues.1 The authors show a rise in the dispensing of intravenous iron agents in the period from 2013 to 2017 for women. They suggest that this may be an issue relating to the inappropriate use of this agent. However, we question whether the data can support this suggestion, and feel this should be viewed cautiously because of the study limitations. The study did not examine the reasons for the escalation in prescriptions.

  • 1 Belgravia Medical Centre, Perth, WA
  • 2 University of Western Australia, Perth, WA
  • 3 Lyell McEwin Hospital, Adelaide, SA


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.